Content about Barbara Kochanowski

February 28, 2014

The Consumer Healthcare Products Association earlier this week voiced support for keeping over-the-counter bronchodilators in the OTC Monograph during a recent meeting of the Food and Drug Administration’s Nonprescription Drugs Advisory Committee.

WASHINGTON — The Consumer Healthcare Products Association earlier this week voiced support for keeping over-the-counter bronchodilators in the OTC Monograph during a recent meeting of the Food and Drug Administration’s Nonprescription Drugs Advisory Committee. 

November 11, 2013

The voluntary action taken five years ago by manufacturers of cough and cold medicines — namely to no longer recommend the use of OTC cough-cold products in children under the age of 4 years unless directed to do so by a doctor — has worked, according to a study published Monday online by Pediatrics, the peer-reviewed journal of the American Academy of Pediatrics.

BURLINGTON, Vt. — The voluntary action taken five years ago by manufacturers of cough and cold medicines — namely to no longer recommend the use of OTC cough-cold products in children under the age of 4 years unless directed to do so by a doctor — has worked, according to a study published Monday online by Pediatrics, the peer-reviewed journal of the American Academy of Pediatrics. 

August 19, 2013

The Consumer Healthcare Products Association asked the Food and Drug Administration to take action to ensure that the millions of caretakers who use acetaminophen products in young children have access to convenient and accurate dosing information.

WASHINGTON — The Consumer Healthcare Products Association on Monday asked the Food and Drug Administration to take action to ensure that the millions of caretakers who use acetaminophen products in young children have access to convenient and accurate dosing information.

June 24, 2013

The Consumer Healthcare Products Association board of directors on Friday approved voluntary labeling guidelines for caffeine-containing dietary supplements discussed during the June 18 board meeting.

WASHINGTON — The Consumer Healthcare Products Association board of directors on Friday approved voluntary labeling guidelines for caffeine-containing dietary supplements discussed during the June 18 board meeting. The voluntary measure was taken in support of the Food and Drug Administration’s suggestion to food and dietary supplement manufacturers to include more information about caffeine on product labels.